Cost-Effectiveness of Saxagliptin Compared To Glp-1 Analogues As An Add-On To Insulin in the Treatment of Type 2 Diabetes Mellitus From A Uk Health Care Perspective
Abstract
Authors
M. Charokopou H. Vioix B. Verheggen L.A. Eddowes M. Griffiths Z. Gabriel K. Tolley M. Sibartie